AAPS Pharm Sci 360 2026 (American Association of Pharmaceutical Scientists)
October 26-28
Ernest Morial Convention Center
New Orleans, LA
Booth #1204
USP Application Compendium
Example USP Monographs & Applicated Instruments:
HPLC per USP <621>, TOC per USP <643> and <661.1-2>, GC per USP <467>, Physical Testing per USP <915> & <1912>, ICP & ICPMS per USP <232> & <233>
Example Additional Applications & Instruments:
HPLC, GC, UV-Vis, FTIR, EDX, ICP, ICPMS, TOC, Physical Testing
FTIR & UV-Vis
Gas Chromatography
- Residual Solvent Analysis in Pharmaceuticals with N2 Carrier Gas Using Nexis GC-2060 and HS-20 NX — JP 18 and USP <467> / Water-Insoluble Samples —
- Residual Solvent Analysis in Pharmaceuticals with N2Carrier Gas Using Nexis GC-2060 and HS-20 NX — JP 18 and USP <467> / Water-Soluble Samples —
- Determination of Organic Impurities from Valproic Acid as per proposed USP monograph GC method
- Determination of Epichlorohydrin from Sevelamer carbonate as per proposed USP monograph GC method
- Alcohol Determination of Sanitizer Gel in accordance with USP <611>
- System Suitability Test of Low-Substituted Hydroxypropyl Cellulose for USP42-NF37
- Analysis of Volatile Impurities in Anhydrous Ethanol and Ethanol for Disinfection in Accordance with the Purity Test set by the Pharmacopoeias (JP, USP, EP)
Gas Chromatography - Residual Solvents
- Analysis of Residual Solvents in Pharmaceuticals An Analysis Method for Class 2 Solvents (Water- vSoluble Samples) Unsuited to Headspace GC Methods
- Analysis of Residual Solvents in Pharmaceuticals by Nexis™ GC-2030 + HS-20 (JP17 Supplement II, USP 467)
- Analysis of Residual Solvents in Pharmaceuticals by Water-Soluble Samples Using N2 Carrier (JP17 Supplement II, USP 467)
- Analysis of Residual Solvents in Pharmaceuticals by Water-Insoluble Samples Using N2 Carrier (JP17 Supplement II, USP 467)
- Efficient Analysis of Residual Solvents in Pharmaceuticals Using the Compact Model, Brevis GC-2050—JP18 and USP467, Water-Soluble Sample
- Residual Solvents Analysis in Pharmaceuticals by HS-GC-FID with Newly Added Compounds –USP <467> Procedure A
- Analysis of Residual Solvents in Pharmaceuticals by Water-Insoluble Samples Using H2Carrier (USP 467)
- Efficient Analysis of Residual Solvents in Pharmaceuticals Using the Compact Model, Brevis GC-2050 (2)
- Using GCMS to Test for Residual Solvents in Pharmaceuticals
High Performance Liquid Chromatography
- High Speed Analysis of Budesonide in Accordance with Chapter 621 in USP 40
- Analysis of Fingolimod Hydrochloride According to the USP Monograph 1745
- High Speed Analysis of Pregabalin in Accordance with Chapter 621 in USP 40
- USP Analysis of Almotriptan Tablets and Related Substances
- Analysis of Mannitol Using RID-20A Differential Index Detector
- Analysis of Omeprazole by "i-Series" for USP and JP Methods
- Analysis of Montelukast Sodium Using Prominence-i and Nexera-i MT
- High-Speed Analysis of Pramipexole following the Draft Guidance of International Harmonization of Pharmacopoeias
- High-Speed Analysis of Linezolid following the Draft Guidance of International Harmonization of Pharmacopoeias
- Analysis of Meloxicam in Accordance with the United States Pharmacopoeia by Nexera XR
- Analysis of Cyanocobalamin tablets, assay procedure 2 as per USP41-NF36 monograph, using Shimadzu Nexera X2 Fast LC System
- High Speed Analysis of Phenytoin in accordance with chapter 621 in USP 39
- High Speed Analysis of Indometacin in accordance with chapter 621 in USP 39
- High Speed Analysis of Topiramate in accordance with chapter 621 in USP 39
- Application of HPLC in Quality Analysis of Hydroxychloroquine Sulfate
- Organic Impurity Analysis of Cetirizine Hydrochloride Drug Material Following USP Monograph
- Determination of Dexamethasone and its organic impurities content as per USP monograph UHPLC method
- Organic Impurity analysis of Levofloxacin Drug Material following USP monograph
- Analysis of Elemental Impurities in Medium chain Triglycerides According to USP
Inductively Coupled Plasma Mass Spectrometry
- Analysis of Pharmaceutical Raw Materials Compliant with ICH Q3D Guideline Using ICP-MS with Collision/Reaction Mode
- Analysis of Elemental Impurities in Oral Drug ProductsUsing ICPMS-2040/2050 ―ICH Q3D―
- Screening Analysis of 24 Elemental Impurity Elements in Drugs Using ICPMS-2040/2050
- Analysis of Dimethicone Based on USP-Specified Method
Physical Testing
TOC (Total Organic Carbon)
- TOC Measurement of Pharmaceutical Water
- TOC System Suitability Test for Sterile Water According to USP
- TOC System Suitability Test Using TOC-1000e According to USP 643
- TOC – Determination according to USP 661.1 Testing of Plastic Packaging Systems and their Materials of Construction
- TOC – Determination according to USP 661.2 Testing of Plastic Packaging Systems and their Materials of Construction
News / Events
-
-
ASMS (American Society for Mass Spectrometry) 2026
May 31 - June 4
San Diego Convention Center
San Diego, CA
Suite 5, 6 -
Pharma Community Network Event
Shimadzu Scientific Instruments and ZefSci invite you and your analytical teams to a pharma community networking event to celebrate 150 years of science and innovation at The Foundry & Lux in South San Francisco. Our event will be built around innovation, collaboration, and connection.
-
Shimadzu Scientific Instruments Opens Boston Location of Its R&D Center Focus will be on promoting customer-oriented development to expand business in the pharmaceutical field
Shimadzu Scientific Instruments, Inc. (SSI, Columbia, Maryland, USA), a Shimadzu Group company, has opened a satellite lab in Boston, Massachusetts to be the base of its collaborative research and development activities on the East Coast. Established to conduct research and development more closely linked to customers, SSI's R&D Center consists of three bases, with the main facilities at its Maryland headquarters, a West Coast location, and this new space in Boston near the city center. The Boston lab was set up by partnering with Labshares, a shared laboratory service provider for life science companies.